Drug recall · July 10, 2013
Lidocaine Hydrochloride and 5% Dextrose Injection recall
Why: Lack of Assurance of Sterilty: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lidocaine Hydrochloride and 5% Dextrose Injection, USP, 2g VIAFLEX Plus Plastic Container, 500mL, Rx Only, Baxter, Deerfield, IL 60015
- Lots / codes
Lot #: Product code 2B0973: P279935, Exp 7/13
- Quantity
- N/A
- Company
- Baxter Healthcare Corp., Deerfield, IL
- Distribution
- Nationwide & Puerto Rico
- Initiated
- May 21, 2013 · Voluntary: Firm initiated
- Classified
- June 28, 2013
- Reported
- July 10, 2013
- Ended
- June 18, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lidocaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.